November 19, 2026·38 min read

Kulicke & Soffa (KLIC), Financial Analysis

Insights derived from analysing SEC filings. Independent analysis, not a publication of the SEC.

Net revenue Q4 FY2026
$410m
+131.1% year on year (Q4 FY2025 $178m)
Costs (revenue less operating income) Q4 FY2026
$323m
+82.9% year on year (Q4 FY2025 $177m)
Operating margin Q4 FY2026
21.2%
+20.7 pts year on year (Q4 FY2025 0.5%)
Key findings
  • Q4 FY2026 (quarter to 3 Oct 2026): revenue $410.3m, +131.1% year on year and +24.2% on Q3; operating margin 21.2% against 0.5%; net income $73.2m against $6.4m; diluted EPS $1.37 against $0.12; non GAAP EPS $1.52. Revenue was $35.3m above the $375m midpoint of the outlook given in Aug 2026 and above the top of its $20m range.
  • Ball Bonding drove the year: FY2026 segment revenue $768.0m, +162.2%, 64.9% of revenue, with operating income of $303.6m (39.5% margin). The FY2026 Form 10-K attributes $402.8m of the $475.0m rise to general semiconductor and $57.2m to memory, on demand related to AI adoption and data center buildouts.
  • Advanced Solutions, which holds the fluxless thermo compression (TCB) bonders for HBM and high performance computing, grew +55.0% to $112.7m in FY2026 and +158.4% to $41.6m in Q4, but posted an operating loss of ($38.4m) as segment R&D rose to $69.5m from $50.3m; FY2025 segment income included the $71.1m Project reimbursement. The 6 May 2026 release expects the added FY2026 capital expenditure to expand TCB system production, supporting up to about $400m of annual TCB system sales; Advanced Solutions system manufacturing began on the newly completed Singapore production floor in Q1 FY2027.
  • FY2026: revenue $1.18bn, +80.9%; gross margin 48.4% against 42.5%; operating income $211.8m against ($3.2m); diluted EPS $3.42; non GAAP EPS $3.95 against $0.21. Operating cash flow fell to $71.9m as receivables rose $241.8m and inventories $87.5m; repurchases paid in the cash flow statement were $10.5m against $97.1m (the release and Form 10-K state 211.0 thousand shares bought at a cost of $10.4m).
  • Orders ran ahead of shipments: FY2026 bookings $1.66bn against $750.8m and backlog $720.3m at 3 Oct 2026 against $245.3m. The Q1 FY2027 outlook is $410m +/‑ $20m, level with Q4 and +105.4% on Q1 FY2026. Destination sales to China were 67.2% of FY2026 revenue and two customers named in the Form 10-K, Haoseng Industrial (16.1%) and Tianshui Huatian Technology (13.5%), took 29.6% together.
  • Shares closed at $66.99 on 18 Nov 2026, 19.6x FY2026 diluted EPS and 17.0x non GAAP EPS, 49.9% below the 1 Jul 2026 close of $133.81. Three year scenario prices from this report's model assumptions: base $80, best $183, worst $19.

Figures are read from the filings of Kulicke and Soffa Industries, Inc. (central index key 56978): the Form 10-K for FY2026 filed 19 Nov 2026 and the Forms 10-K for FY2023 to FY2025, the Forms 10-Q for Q1 to Q3 FY2026, the Forms 8-K with all their exhibits, incl. the quarterly results releases (Ex 99.1) for Q1 FY2025 to Q4 FY2026, the CEO offer letter and appointment release, the amended incentive plan and the Item 5.07 vote results, the proxy statement of 22 Jan 2026, Schedules 13G and Forms 4, together with the Forms 10-Q and 10-K of Teradyne and Onto Innovation and the Applied Materials figures used in this series' Applied Materials post. Kulicke & Soffa files no separate CFO commentary document; CFO commentary is the statement of Lester Wong, Interim CEO and CFO from Dec 2025 to Aug 2026, in each results release. No earnings call content is used. Accession numbers appear in the Sources appendix. Share prices are closes of 18 Nov 2026, the day the Q4 FY2026 release was filed.

1 Revenue & Business Model

  • Storyline: Kulicke & Soffa sells the machines that connect a chip to its package, with wire (ball and wedge bonders), with thermo compression and with other advanced packaging tools, plus the capillaries, blades, spares and services those machines consume. FY2026 revenue rose 80.9% after three years of decline from the FY2022 level of $1.50bn. Chapters 2 to 4 follow the three revenue drivers: Ball Bonding, Advanced Solutions (incl. TCB for AI and HBM) and APS.
  • Business model (FY2026 Form 10-K): four reportable segments, Ball Bonding Equipment, Wedge Bonding Equipment, Advanced Solutions and Aftermarket Products and Services (APS), plus All Others (advanced dispense and the Electronics Assembly business being wound down). Customers are OSATs, IDMs, foundries and electronics makers; 94.0% of FY2026 revenue shipped outside the US.
  • Segment basis: from FY2026 one product line moved from APS to All Others with the cessation of the Electronics Assembly equipment business; FY2025 and FY2024 segment figures in this report are the recast figures from the FY2026 Form 10-K. Q1 and Q4 segment figures are derived from filed year to date totals.
  • Revenue FY2022 $1.50bn to FY2026 $1.18bn: revenue fell 50.6% in FY2023, 4.9% in FY2024 and 7.4% in FY2025, then rose +80.9% in FY2026. Quarterly revenue rose in each quarter of FY2026, from $199.6m in Q1 to $410.3m in Q4.
  • Regions and customers, FY2026: destination sales to China $795.4m, +118.8%, 67.2% of revenue; customers headquartered in China 56.3% against 53.5%. Haoseng Industrial was 16.1% and Tianshui Huatian Technology 13.5% of revenue; they held 32.6% and 22.2% of receivables at 3 Oct 2026 (54.8% together).
  • Employees: 2,500 full time employees and 476 temporary workers at 3 Oct 2026 (Form 10-K). Ball, wedge and TCB bonders are built in Singapore; capillaries, dicing blades and part of the bonding wedges in China.
Figure 1.1 Revenue and operating margin, FY2022 to FY2026
Figure 1.2 Revenue mix by segment, quarterly (% of revenue)
Table 1.1 Segment revenue, Q4 FY2026 and FY2026 against the prior year ($m)
SegmentQ4 FY2025Q4 FY2026Change (%)FY2025FY2026Change (%)Share FY2026 (%)
Ball Bonding Equipment91.0271.4198.3293.0768.0162.264.9
Wedge Bonding Equipment20.042.3110.9110.6102.3(7.5)8.6
Advanced Solutions16.141.6158.472.7112.755.09.5
APS33.840.921.2128.9151.017.212.8
All Others16.714.0(15.9)48.948.90.04.1
Total177.6410.3131.1654.11,182.980.9100.0
FY2026 Form 10-K and Forms 10-Q; FY2025 recast. Q4 values are full year less nine months.
Table 1.2 Segment gross margin and operating income, FY2025 and FY2026
SegmentGross margin FY2025 (%)Gross margin FY2026 (%)Operating income FY2025 ($m)Operating income FY2026 ($m)Operating margin FY2025 (%)Operating margin FY2026 (%)
Ball Bonding Equipment50.049.984.4303.628.839.5
Wedge Bonding Equipment45.140.618.43.916.63.8
Advanced Solutions58.044.449.4(38.4)67.9(34.0)
APS51.650.944.450.234.533.3
All Others(54.7)42.6(104.8)(1.3)(214.3)(2.6)
Unallocated corporate expensesn/an/a(95.0)(106.3)n/an/a
Total42.548.4(3.2)211.8(0.5)17.9
FY2026 Form 10-K Item 7 and Note 15. FY2025 Advanced Solutions includes the $71.1m reimbursement from the cancelled Project; FY2025 All Others includes EA cessation charges.
Table 1.3 Revenue by end market ($m)
End marketFY2024FY2025FY2026Change FY2026 (%)Share FY2026 (%)
General Semiconductor333.8334.2804.1140.668.0
Memory73.653.4104.795.98.8
Automotive and Industrial138.8110.495.3(13.7)8.1
APS160.0156.1178.914.615.1
FY2026 Form 10-K Note 15. The APS end market line ($178.9m) is wider than the APS segment ($151.0m), as filed.
Table 1.4 Destination sales by country ($m)
CountryFY2024FY2025FY2026Change FY2026 (%)Share FY2026 (%)
China416.7363.6795.4118.867.2
Taiwan59.355.087.959.77.4
United States66.162.270.914.06.0
Malaysia54.345.858.828.45.0
All others109.8127.4169.933.314.4
Country of the customer facility to which products were shipped (FY2026 Form 10-K Note 15).

2 Ball Bonding: $768m in FY2026, +162%, on AI and Data Center Capacity

  • Ball Bonding revenue was $271.4m in Q4 FY2026 against $91.0m, +198.3% (derived), and $768.0m in FY2026, +162.2%. The segment made up 64.9% of FY2026 revenue against 44.8% in FY2025.
  • Drivers in the FY2026 Form 10-K: of the $475.0m rise, $402.8m came from general semiconductor, $57.2m from memory and $15.1m from automotive and industrial, on demand related to AI adoption and global data center buildouts leading to capacity expansion in certain regions.
  • Margins: segment gross margin 49.9% against 50.0%; operating margin 39.5% against 28.8% which the FY2026 Form 10-K attributes to higher revenue, partly offset by higher staff costs and sales commissions; Q4 operating margin 41.6% (derived).
  • End markets, all segments: general semiconductor $804.1m, +140.6%; memory $104.7m, +95.9%; automotive and industrial $95.3m, (13.7%).
  • Wedge Bonding, the power semiconductor and battery bonder line, fell (7.5%) to $102.3m in FY2026 on lower EV capacity needs, with operating income of $3.9m; Q4 revenue rose to $42.3m from $20.0m.
Figure 2.1 Ball Bonding revenue and operating margin by quarter
Figure 2.2 Revenue by end market FY2024 to FY2026

How the assembly and test equipment market is changing

  • KLIC FY2026 Form 10-K, Item 7: Ball Bonding revenue +$475.0m, of which general semiconductor $402.8m, memory $57.2m and automotive and industrial $15.1m, on demand related to AI adoption and data center buildouts leading to capacity expansion in certain regions.
  • KLIC FY2026 Form 10-K, Item 1: customers headquartered in China took 56.3% of FY2026 revenue against 53.5%; destination sales to China $795.4m, 67.2% of revenue.
  • KLIC FY2026 Form 10-K, Item 1: ATPremier MEM PLUS vertical wire (Mar 2025) extends ball bonding into DRAM and NAND assembly; the 10-K names copper wire bonding processes as a cost reduction for IC assembly.
  • Teradyne 10-Q for the Sep 2026 quarter: Semiconductor Test revenue $1.07bn, +76.9%; memory test revenue $301m against $128m.
  • Onto Innovation 10-Q for the Sep 2026 quarter: revenue $409.7m, +87.8% (incl. Semilab USA, acquired Nov 2025); systems and software revenue $358.3m, +106.2%.
  • Competitors named in the FY2026 Form 10-K: ASM Pacific Technology, Hesse, Han's Laser, BE Semiconductor Industries, Hanwha Precision Machinery, Hanmi Semiconductor and Nordson; none of the first six file with the SEC.
Figure 2.3 Revenue growth year on year, Kulicke & Soffa, Onto, Teradyne and Applied
Table 2.1 Ball Bonding and total results against SEC filing peers
Company and measurePeriodDetailValueChange year on year (%)
Kulicke & Soffa, Ball Bonding revenue ($m)Oct 2026 quarteroperating margin 41.6%; FY2026 $768.0m271.4198.3
Kulicke & Soffa, total revenue ($m)Oct 2026 quarteroperating margin 21.2%410.3131.1
Teradyne, Semiconductor Test revenue ($m)Sep 2026 quarterpretax segment income $366.9m; memory test $301m1,072.076.9
Onto Innovation, revenue ($m)Sep 2026 quartergross margin 54.8%; incl. Semilab USA409.787.8
Applied Materials, Semiconductor Systems revenue ($m)Oct 2026 quarterDRAM 33% of segment revenue7,996.063.9
Each company's own measures from its filings. Kulicke & Soffa quarter ends 3 Oct 2026; Teradyne 27 Sep, Onto 30 Sep, Applied 25 Oct 2026.

3 Advanced Solutions and TCB: $112.7m in FY2026 and TCB Production for up to about $400m of Annual Sales

  • Advanced Solutions revenue $41.6m in Q4 FY2026 against $16.1m, +158.4% (derived); FY2026 $112.7m, +55.0%. The segment holds fluxless thermo compression (APTURA), wafer level and die attach systems; the FY2026 Form 10-K names high performance computing, high bandwidth memory and co packaged optics as TCB applications.
  • Drivers in the FY2026 Form 10-K: general semiconductor volume +$56.9m on AI adoption, data center buildouts and heterogeneous packaging, partly offset by ($15.1m) in LED products.
  • Profit: gross margin 44.4% against 58.0% on product mix (Q3 FY2026 34.7%); operating loss ($38.4m) against income of $49.4m in FY2025, which included the $71.1m Project reimbursement. Segment R&D was $69.5m, 40.3% of all R&D.
  • Capacity: in May 2026 FY2026 capital expenditure was raised to about $22m from about $12m to expand TCB system production, supporting up to about $400m of annual TCB system sales (8-K Ex 99.1 of 6 May 2026); Advanced Solutions segment capital expenditure was $17.1m of $27.1m for all segments in FY2026 (Note 15; cash paid $21.8m) and FY2027 capital expenditure is planned at $30.0m to $34.0m. Advanced Solutions system manufacturing began on the newly completed Singapore production floor in Q1 FY2027.
Figure 3.1 Advanced Solutions revenue and operating income by quarter

How advanced packaging equipment is changing

  • Applied Materials 8-K of 26 Oct 2026: accelerated purchase to raise its stake in BE Semiconductor Industries to about 20%, covering hybrid bonding and die on wafer integration.
  • Applied Materials 8-K Ex 99.1 of 13 Aug 2026: six new DRAM and packaging systems, incl. Producer Avila 2 for 12 and 16 high HBM stacks.
  • Teradyne 10-Q for the Sep 2026 quarter: $300m minority investment in FormFactor agreed 6 Oct 2026, with a collaboration on test solutions incl. advanced packaging and high bandwidth memory.
Figure 3.2 Packaging related revenue growth year on year
Table 3.1 Advanced packaging results against SEC filing peers
Company and measurePeriodDetailValueChange year on year (%)
Kulicke & Soffa, Advanced Solutions revenue ($m)Oct 2026 quarterFY2026 $112.7m, +55.0%; operating loss41.6158.4
Onto Innovation, systems and software revenue ($m)Sep 2026 quartertotal revenue $409.7m, +87.8%358.3106.2
Applied Materials, total revenue ($m)Oct 2026 quarterstake in Besi to rise to about 20%10,409.053.1
Teradyne, Product Test revenue ($m)Sep 2026 quarterpretax segment income $41.4m138.156.5
BE Semiconductor Industries (Besi), named as a competitor in the FY2026 Form 10-K and the company in which Applied is raising its stake to about 20%, does not file with the SEC and is not included.

4 APS: $151.0m in FY2026 at a 33.3% Operating Margin

  • APS revenue $40.9m in Q4 FY2026, +21.2% (derived); FY2026 $151.0m, +17.2%; operating income $50.2m (33.3%) against $44.4m (34.5%).
  • Drivers in the FY2026 Form 10-K: spares and services +$14.8m and bonding tools +$7.3m. APS sells capillaries, dicing blades, wedge bonder tools, spares, repair and upgrades, incl. for other makers' equipment.
  • Demand pattern: the 10-K states that APS follows semiconductor unit consumption more than capacity additions and has been less volatile than the equipment segments; its share of revenue fell to 12.8% from 19.7% as equipment revenue grew faster.
  • Gross margin 50.9% against 51.6%, the highest of the four segments in FY2026.
Figure 4.1 APS revenue and operating margin by quarter

How equipment aftermarket revenue is changing

  • Applied Materials 8-K Ex 99.1 of 12 Nov 2026: Applied Global Services revenue $1.90bn in the Oct 2026 quarter, +25.9%.
  • Onto Innovation 10-Q for the Sep 2026 quarter: parts and services revenue $51.4m against $44.4m.
Figure 4.2 Aftermarket and service revenue growth year on year
Table 4.1 Aftermarket results against SEC filing peers
Company and measurePeriodDetailValueChange year on year (%)
Kulicke & Soffa, APS revenue ($m)Oct 2026 quarterFY2026 $151.0m, operating margin 33.3%40.921.2
Applied Materials, Applied Global Services revenue ($m)Oct 2026 quarterservices, spares and automation software1,896.025.9
Onto Innovation, parts and services revenue ($m)Sep 2026 quarterparts $28.5m, services $23.0m51.415.8
Applied Global Services includes services, spares and automation software; Onto parts and services.

5 Financial Analysis & Ratios

  • Operating margin FY2026 17.9% against (0.5%) in FY2025, (13.1%) in FY2024 and 31.3% in FY2022. FY2025 included a $76.0m gain on the cessation of business (incl. the $71.1m Project reimbursement), $39.8m of impairments and inventory write downs; FY2026 carried $0.9m of impairment.
  • Quarterly path: GAAP operating margin rose from 8.9% in Q1 FY2026 to 21.2% in Q4; gross margin was 49.6% in Q1 and 47.8% in Q4; the Q3 FY2026 Form 10-Q attributes the lower Advanced Solutions gross margin (34.7% against 46.8%) to product mix.
  • Net income FY2026 $182.6m (15.4% of revenue); the effective tax rate was 21.1% against 99.0% in FY2025, when the Project reimbursement and EA cessation were taxed as discrete items. Interest income fell to $18.1m from $23.8m on lower rates.
  • Balance sheet at 3 Oct 2026: cash and short term investments $517.0m and no debt; receivables $425.2m against $183.5m (Haoseng 32.6% of the balance), inventories $237.5m against $160.2m; accounts payable $129.2m against $57.2m; contract liabilities $64.0m against $23.9m.
  • Commitments: inventory purchase obligations $608.7m at 3 Oct 2026, almost all due within a year, against $359.6m at 4 Apr 2026; $223.3m left under the $300m buyback program; dividend $0.205 a quarter.
Table 5.1 Income statement, cash flow and balance sheet summary ($m unless stated)
Line itemFY2022FY2023FY2024FY2025FY2026
Revenue1,503.6742.5706.2654.11,182.9
Gross profit748.3358.7268.8277.9572.6
Research and development136.9144.7151.2149.6172.5
Selling, general and administrative140.1153.0165.6167.7187.3
Operating income470.139.4(92.5)(3.2)211.8
Net income433.557.1(69.0)0.2182.6
Diluted EPS ($)7.090.99(1.24)0.003.42
Operating cash flow390.2173.431.0112.471.9
Capital expenditure(23.0)(44.4)(16.1)(17.2)(21.8)
Free cash flow367.2129.014.995.250.1
Stock based compensation19.022.726.928.526.9
Cash and investments775.5759.4577.1510.7517.0
Total debt0.00.00.00.00.0
Total equity1,194.71,174.6944.0821.5982.0
$m. FY2022 to FY2026 from the Forms 10-K (FY2026 filed 19 Nov 2026). Free cash flow is operating cash flow less capital expenditure. Cash and investments are cash plus short term investments. Kulicke & Soffa has no debt. TTM equals FY2026 and is not shown separately.
Figure 5.1 Quarterly revenue and margins
Table 5.2 What changed, Q4 FY2026 against Q4 FY2025
MetricQ4 FY2025Q4 FY2026Change
Revenue ($m)177.6410.3131.1%
Gross profit ($m)81.2196.0141.3%
Operating income ($m)0.987.2n/a
Net income ($m)6.473.21,048.0%
Diluted EPS ($)0.121.371,041.7%
Operating cash flow ($m)7.425.4242.4%
Free cash flow ($m)4.414.6227.5%
Operating margin (%)0.521.220.7 pts
Net margin (%)3.617.814.3 pts
Table 5.3 Ratio analysis
RatioFY2022FY2023FY2024FY2025FY2026
Growth and margins
Revenue growth (%)n/a(50.6)(4.9)(7.4)80.9
Gross margin (%)49.848.338.142.548.4
Operating margin (%)31.35.3(13.1)(0.5)17.9
Net margin (%)28.87.7(9.8)0.015.4
FCF margin (%)24.417.42.114.64.2
Cost and investment intensity
R&D (%) revenue9.119.521.422.914.6
SBC (%) revenue1.33.13.84.42.3
Capex (%) revenue1.56.02.32.61.8
Effective tax rate (%)9.120.8n/a99.021.1
Returns
ROE (%)36.34.8(6.5)0.020.2
ROA (%)27.33.7(5.0)0.014.3
ROIC (%)101.97.5(20.7)(0.9)35.9
Asset turnover (x)0.950.500.570.590.82
Liquidity and leverage
Current ratio (x)5.366.555.414.793.37
Debt to equity (x)0.000.000.000.000.00
Net cash ($bn)0.80.80.60.50.5
Efficiency and cash quality
Days sales outstanding7578100102131
Inventory days89207148155142
FCF to net income (x)0.852.26n/a446.980.27
Shareholder returns (%) FCF87861,30915985
ROE and ROA use average balances. ROIC uses operating income after tax over equity less cash and investments. Net cash is cash and investments, as there is no debt. FY2024 and FY2025 ratios reflect losses and one time items.
Figure 5.2 Margin profile
Figure 5.3 Operating cash flow, capital expenditure and free cash flow
Table 5.4 Valuation snapshot at $66.99 per share, 18 Nov 2026
MeasureValue
Market value ($bn)3.5
Enterprise value, net cash of $517.0m deducted ($bn)3.0
P/E on FY2026 diluted EPS of $3.42 (x)19.6
P/E on FY2026 non GAAP EPS of $3.95 (x)17.0
P/E on Q1 FY2027 non GAAP EPS outlook of $1.65 annualized (x)10.2
EV/Sales, FY2026 (x)2.6
Free cash flow yield, FY2026 (%)1.4
Dividend yield at $0.205 a quarter (%)1.2
Price to book (x)3.6

Cost structure, segment profit, EPS and cash returns

  • Cost of sales was 51.6% of FY2026 revenue against 57.5% in FY2025 and 50.2% in FY2022; R&D 14.6% against 22.9%; SG&A 15.8% against 25.6%.
  • Q4 FY2026 costs (revenue less operating income) $323.1m, +82.9%, against revenue +131.1%; operating margin 21.2% against 0.5%.
  • Segment profit FY2026: Ball Bonding $303.6m (39.5%); APS $50.2m (33.3%); Wedge Bonding $3.9m; Advanced Solutions ($38.4m); unallocated corporate costs ($106.3m).
  • Cash returns FY2026: buybacks paid $10.5m (cash flow statement; $10.4m cost as stated in the release) and dividends paid $32.2m against free cash flow of $50.1m; FY2025 buybacks were $97.1m. Diluted shares averaged 53.4m against 53.2m.
Figure 5.4 Main cost lines as % of revenue by year
Figure 5.5 Segment operating income by quarter
Figure 5.6 GAAP and non GAAP diluted EPS by quarter
Figure 5.7 Revenue outlook range against revenue reported by quarter
Figure 5.8 Free cash flow against share repurchases by quarter
Table 5.5 Cost lines as % of revenue, FY2022 to FY2026
LineFY2022FY2023FY2024FY2025FY2026
Cost of sales (% of revenue)50.251.761.957.551.6
Research and development (% of revenue)9.119.521.422.914.6
Selling, general and administrative (% of revenue)9.320.623.425.615.8
Capital expenditure (% of revenue)1.56.02.32.61.8
Operating income (% of revenue)31.35.3(13.1)(0.5)17.9
Table 5.6 Quarterly margins, costs and EPS, last five quarters
LineQ4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026
Revenue ($m)177.6199.6242.6330.4410.3
Gross margin, US GAAP (%)45.749.649.347.847.8
Operating margin, US GAAP (%)0.58.915.920.721.2
Operating margin, non GAAP (%)6.612.619.122.923.5
Research and development ($m)38.840.438.443.949.8
Selling, general and administrative ($m)41.540.842.745.858.0
Diluted EPS, US GAAP ($)0.120.320.661.071.37
Diluted EPS, non GAAP ($)0.280.440.791.201.52
Forms 8-K Ex 99.1; Q4 FY2025 SG&A as restated in the FY2026 releases.
Table 5.7 GAAP to non GAAP net income and EPS
Item ($m unless stated)Q4 FY2026Q4 FY2025FY2026FY2025
GAAP net income ($m)73.26.4182.60.2
Equity based compensation7.57.826.928.5
Restructuring0.62.83.212.7
Impairment charges0.9n/a0.939.8
Amortization of acquired intangibles0.30.31.23.0
Gain relating to cessation of businessn/an/an/a(76.0)
Other items and tax effect of adjustments(1.2)(2.4)(3.9)2.7
Non GAAP net income ($m)81.414.9210.911.0
Non GAAP diluted EPS ($)1.520.283.950.21
As filed in the Forms 8-K Ex 99.1 of 18 Nov 2026 and 19 Nov 2025; rows may not sum due to rounding.
Table 5.8 Cash flow and share repurchases, last five quarters ($m)
LineQ4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026
Operating cash flow7.4(8.9)10.345.225.4
Capital expenditure(3.0)(2.7)(4.1)(4.3)(10.8)
Free cash flow4.4(11.6)6.240.914.6
Share repurchases(16.7)(6.7)(0.1)(0.5)(3.1)
Cash flow amounts from the Forms 8-K Ex 99.1; repurchases as stated in each release.

6 MD&A & Management Commentary

Q4 FY2026 results: Form 8-K Ex 99.1 of 18 Nov 2026 and FY2026 Form 10-K

  • Q4 FY2026: revenue $410.3m against $177.6m; gross margin 47.8% against 45.7%; operating income $87.2m (21.2%) against $0.9m; net income $73.2m; diluted EPS $1.37; non GAAP EPS $1.52; operating cash flow $25.4m; adjusted free cash flow $14.6m.
  • Against Q3 FY2026: revenue +24.2%; Ball Bonding +20.1% to $271.4m; Advanced Solutions +41.5% to $41.6m; Wedge Bonding +64.0% to $42.3m; APS +14.4% to $40.9m (derived).
  • Costs: R&D $49.8m in Q4, +28.2%, and $172.5m in FY2026, +15.3%, incl. $12.4m of higher incentive pay, $9.2m of prototype materials and a $2.5m consortium fee; SG&A $187.3m in FY2026, +11.7%, incl. $16.8m of higher incentive pay and $6.2m of sales commissions, less $9.4m of lower severance.
  • Other items in Q4 FY2026: impairment $0.9m; other gains $1.8m, mainly unrealized gains on equity investments; GAAP tax rate 21.9%; diluted shares 53.6m against 52.5m.
  • Leadership: Fusen Chen retired as CEO on 1 Dec 2025; CFO Lester Wong served as Interim CEO until Raj Talluri, formerly CEO of Enovix and a Micron executive, became President and CEO on 1 Sep 2026. Wong remains CFO.
  • Q1 to Q3 FY2026 in brief: Q1 revenue $199.6m with operating cash flow of ($8.9m); Q2 $242.6m and the TCB capacity plan; Q3 $330.4m, +122.6%, with Ball Bonding at $226.1m.
Table 6.1 Company outlook and revisions, Q2 FY2025 to Q1 FY2027, as filed
ItemOutlookSource
Q2 FY2025 outlook (4 Feb 2025)revenue $165m +/‑ $10m; non GAAP EPS $0.19 +/‑ 10%; actual $162.0m and ($0.52)8-K Ex 99.1 of 4 Feb 2025 and 6 May 2025
Q3 FY2025 outlook (6 May 2025)revenue $145m +/‑ $10m; non GAAP EPS $0.05 +/‑ 10%; actual $148.4m and $0.078-K Ex 99.1 of 6 May 2025 and 6 Aug 2025
Q4 FY2025 outlook (6 Aug 2025)revenue $170m +/‑ $10m; non GAAP EPS $0.22 +/‑ 10%; actual $177.6m and $0.288-K Ex 99.1 of 6 Aug 2025 and 19 Nov 2025
Q1 FY2026 outlook (19 Nov 2025)revenue $190m +/‑ $10m; GAAP EPS $0.18, non GAAP EPS $0.33, each +/‑ 10%; actual $199.6m, $0.32 and $0.448-K Ex 99.1 of 19 Nov 2025 and 4 Feb 2026
Q2 FY2026 outlook (4 Feb 2026)revenue $230m +/‑ $10m; GAAP EPS $0.53, non GAAP EPS $0.67; actual $242.6m, $0.66 and $0.798-K Ex 99.1 of 4 Feb 2026 and 6 May 2026
Q3 FY2026 outlook (6 May 2026)revenue $310m +/‑ $20m; GAAP EPS $0.87, non GAAP EPS $1.00; actual $330.4m, $1.07 and $1.208-K Ex 99.1 of 6 May 2026 and 5 Aug 2026
Q4 FY2026 outlook (5 Aug 2026)revenue $375m +/‑ $20m; GAAP EPS $1.29, non GAAP EPS $1.42; actual $410.3m, $1.37 and $1.528-K Ex 99.1 of 5 Aug 2026 and 18 Nov 2026
Q1 FY2027 outlook (18 Nov 2026), quarter to 2 Jan 2027revenue $410m +/‑ $20m; GAAP EPS $1.48, non GAAP EPS $1.65, each +/‑ 10%; GAAP operating expenses $98.9m +/‑ 2%; 53.5m diluted shares8-K Ex 99.1 of 18 Nov 2026
FY2026 capital expenditureraised to about $22m from about $12m (May 2026) to expand TCB production for up to about $400m of annual TCB system sales; actual $21.8m8-K Ex 99.1 of 6 May 2026; FY2026 Form 10-K
FY2027 capital expenditure$30.0m to $34.0mFY2026 Form 10-K, Item 7
Advanced Solutions productionexpanded facility to be completed in H2 FY2027 (Aug 2026); system manufacturing began on the new Singapore production floor in Q1 FY2027 (Nov 2026)8-K Ex 99.1 of 5 Aug 2026 and 18 Nov 2026

Management and CFO commentary

  • CFO Lester Wong as Interim CEO, Q1 FY2026 release (4 Feb 2026): preparing for higher near term capacity needs of customers; prior investments in power semiconductor, advanced dispense, vertical wire and fluxless TCB named as the base for wider market access.
  • Wong, Q2 FY2026 release (6 May 2026): demand ran above plan on technology and capacity needs in general semiconductor, memory, automotive and industrial markets; capital expenditure raised for Advanced Solutions growth.
  • Wong, Q3 FY2026 release (5 Aug 2026): sequential growth in Q3 with demand improving across all end markets.
  • CEO Raj Talluri, Q4 FY2026 release (18 Nov 2026): wire bonding demand described as resilient; technology moving with AI, data center and advanced packaging trends; more visibility in Advanced Solutions.
Table 6.2 Management statements in their own words
SpeakerDate and sourceStatement
Lester Wong, Interim CEO and CFO6 May 2026, 8-K Ex 99.1“Demand is stronger than anticipated due to both technology and capacity needs”
Lester Wong, Interim CEO and CFO5 Aug 2026, 8-K Ex 99.1“demand conditions continue to improve across all end markets”
Raj Talluri, President and CEO18 Nov 2026, 8-K Ex 99.1“core wire bonding demand is resilient”
Table 6.3 Key disclosures in the FY2026 Form 10-K and the FY2026 Forms 10-Q
ItemDisclosure
FY2026 Form 10-K, Item 1Customers are IDMs, OSATs, foundries and electronics makers; 94.0% of FY2026 revenue shipped outside the US and 56.3% went to customers headquartered in China (53.5% in FY2025).
FY2026 Form 10-K, Item 1, backlogBacklog $720.3m at 3 Oct 2026 against $245.3m; FY2026 bookings $1.66bn against $750.8m; most orders can be cancelled or deferred with limited or no penalties.
FY2026 Form 10-K, Item 1, competitionNamed equipment competitors: ASM Pacific Technology, Hesse, Han's Laser, BE Semiconductor Industries, Hanwha Precision Machinery, Hanmi Semiconductor and Nordson.
FY2026 Form 10-K, Item 1, productsAPTURA fluxless thermo compression bonding targets high performance computing, high bandwidth memory and co packaged optics; ATPremier MEM PLUS vertical wire for DRAM and NAND (Mar 2025); ASTERION TW terminal welding for power modules.
FY2026 Form 10-K, Item 1, people2,500 full time employees and 476 temporary workers at 3 Oct 2026; CEO Fusen Chen retired 1 Dec 2025; Raj Talluri CEO from 1 Sep 2026.
FY2026 Form 10-K, Note 16Haoseng Industrial was 16.1% and Tianshui Huatian Technology 13.5% of FY2026 revenue; the two held 32.6% and 22.2% of receivables at 3 Oct 2026.
FY2026 Form 10-K, Note 15Destination sales to China $795.4m (67.2% of revenue) against $363.6m; long lived assets $103.5m, of which Singapore $58.4m.
FY2026 Form 10-K, Item 7Inventory purchase obligations $608.7m at 3 Oct 2026, of which $607.2m due within a year (Apr 2026: $359.6m); no borrowings other than a bank guarantee.
FY2026 Form 10-K, Item 7, liquidityCash and short term investments $517.0m, of which $334.8m held by foreign subsidiaries; receivables rose $241.8m and inventories $87.5m in FY2026.
FY2026 Form 10-K, Item 5$223.3m left under the $300m buyback program at 3 Oct 2026; Q4 FY2026 purchases of 35 thousand shares at $84.04 to $96.15; dividend $0.205 a quarter.
FY2026 Form 10-K, Note 17Wind down of the Electronics Assembly equipment business substantially completed, subject to last time orders; FY2025 included a $71.1m Project reimbursement and $39.8m of impairments.
FY2026 Form 10-K, Note 16, warrantyWarranty provision $19.6m in FY2026 against $9.4m; reserve $13.1m at year end against $7.3m.
Q3 FY2026 Form 10-Q, MD&ABall Bonding revenue +$150.1m year on year in Q3: general semiconductor $126.6m, memory $19.4m, automotive and industrial $4.1m; Advanced Solutions gross margin 34.7% against 46.8% on product mix.
Q2 FY2026 Form 10-Q, MD&AWedge Bonding revenue (63.9%) in Q2 on lower EV capacity needs; Ball Bonding gross margin 48.3% against 50.8% on customer mix.
FY2026 Forms 10-Q, Part II Item 1AEach of the three FY2026 quarterly reports states no material change to the FY2025 risk factors.

7 Sector & Competitor Analysis

  • Sector: semiconductor assembly, test and process control equipment. Kulicke & Soffa sells back end bonding equipment; Teradyne sells test systems, Onto Innovation inspection, metrology and lithography for advanced packaging, and Applied Materials front end equipment plus packaging tools. All four grew revenue in their latest quarter.
  • Size, TTM: Applied $34.45bn, Teradyne $5.00bn, Onto $1.31bn and Kulicke & Soffa $1.18bn.
  • Latest quarter growth: Kulicke & Soffa +131.1% (Oct 2026 quarter), Onto +87.8% (incl. Semilab USA) and Teradyne +69.8% (Sep 2026 quarters), Applied +53.1% (Oct 2026 quarter).
  • Margins, US GAAP TTM: operating margin Teradyne 32.1%, Applied 32.2%, Kulicke & Soffa 17.9%, Onto 15.7%; free cash flow margin Kulicke & Soffa 4.2% against 18.0% to 20.5% for the peers, as Kulicke & Soffa's receivables and inventories rose.
  • Valuation: P/E TTM Kulicke & Soffa 19.6x, Teradyne 27.0x, Applied 30.2x (12 Nov 2026 close), Onto 66.1x; EV/Sales 2.6x against 7.2x to 8.6x for the peers.
Table 7.1 Kulicke & Soffa and SEC filing equipment peers, latest trailing twelve months, US GAAP
CompanyRevenue TTM ($bn)Revenue growth (%)Gross margin (%)Operating margin (%)Net margin (%)FCF margin (%)ROE (%)Net cash ($bn)Market value ($bn)EV/Sales (x)P/E TTM (x)
KLIC1.2131.148.417.915.44.220.20.542.619.6
AMAT34.553.150.032.229.318.043.47.63028.630.2
TER5.069.859.332.127.520.542.40.6377.227.0
ONTO1.387.851.715.711.518.97.4(0.2)107.766.1
Kulicke & Soffa FY2026 (to 3 Oct 2026), close $66.99 on 18 Nov 2026. Applied Materials FY2026 (to 25 Oct 2026), close $380.95 on 12 Nov 2026, as in this series' Applied Materials post. Teradyne TTM to 27 Sep 2026 and Onto Innovation TTM to 30 Sep 2026, closes 18 Nov 2026. Revenue growth is the latest quarter year on year. Onto net cash is after $1.47bn of 2031 convertible notes and excludes its Rigaku stake. BE Semiconductor Industries, ASMPT, Hanmi and Hanwha do not file with the SEC and are not included.
Figure 7.1 Revenue growth versus operating margin, peer set

8 Material Events & Contracts

  • Eight Forms 8-K from 19 Nov 2025 to 18 Nov 2026: five results releases (Q4 FY2025 to Q4 FY2026), the annual meeting results, the CEO appointment and the amended incentive plan. No Form 8-K/A was filed. The Form 8-K of 28 Oct 2025 announced the retirement of CEO Fusen Chen from 1 Dec 2025.
  • CEO appointment (8-K of 17 Aug 2026): Raj Talluri became President and CEO on 1 Sep 2026 with a $14.0m new hire equity award; Lester Wong returned to the CFO role only.
  • Incentive plan (8-K of 14 Oct 2026): FY2027 bonuses move to operating profit and gross margin.
  • No acquisitions, debt issues or material supply contracts were filed in the period; the main commitments are $608.7m of inventory purchase obligations.
Table 8.1 Forms 8-K filed in the last twelve months
DateItemsEvent
19 Nov 20252.02, 9.01Q4 FY2025 results: revenue $177.6m, GAAP EPS $0.12, non GAAP EPS $0.28; FY2025 revenue $654.1m, net income $0.2m; Q1 FY2026 outlook $190m
4 Feb 20262.02, 9.01Q1 FY2026 results: revenue $199.6m +20.2%, GAAP EPS $0.32, non GAAP EPS $0.44; Q2 outlook $230m
5 Mar 20265.07Annual meeting of 4 Mar 2026: Peter T. Kong and Jon A. Olson elected; PwC ratified; say on pay approved
6 May 20262.02, 9.01Q2 FY2026 results: revenue $242.6m +49.8%, GAAP EPS $0.66, non GAAP EPS $0.79; FY2026 capex raised to about $22m for TCB capacity of up to about $400m a year; Q3 outlook $310m
5 Aug 20262.02, 9.01Q3 FY2026 results: revenue $330.4m +122.6%, GAAP EPS $1.07, non GAAP EPS $1.20; Q4 outlook $375m
17 Aug 20265.02, 7.01, 9.01Dr. Raj Talluri appointed President and CEO from 1 Sep 2026 and director from 17 Aug 2026; $750,000 salary, 110% target bonus, $14.0m new hire equity award; Lester Wong remains CFO
14 Oct 20265.02, 9.01Amended Incentive Compensation Plan for FY2027: operating profit and gross margin (50% each) replace net income and operating margin; 15% individual goals for the Executive Leadership Team
18 Nov 20262.02, 9.01Q4 FY2026 results: revenue $410.3m +131.1%, GAAP EPS $1.37, non GAAP EPS $1.52; FY2026 revenue $1.18bn, EPS $3.42; Q1 FY2027 outlook $410m
Table 8.2 Material contracts and financing arrangements
ContractTerms
CEO offer letter, Raj Talluri (13 Aug 2026)Salary $750,000; target bonus 110% of salary; new hire equity award of $14.0m (half RSUs over three years, half PSUs on relative total shareholder return); annual award $6.0m (40% RSUs, 60% PSUs); 24 months of salary on termination without cause; salary and target bonus times two on a change in control.
Incentive Compensation Plan (amended 13 Oct 2026)From FY2027 corporate measures are operating profit and gross margin, 50% each, in place of net income and operating margin; Executive Leadership Team awards 85% corporate and 15% individual goals.
Share repurchase program$300m program announced 13 Nov 2024 with a Rule 10b5‑1 plan from 2 Dec 2024 to 2 Dec 2029; $223.3m remaining at 3 Oct 2026.
Inventory purchase obligations$608.7m at 3 Oct 2026, of which $607.2m due in FY2027; part non cancellable and part subject to cancellation charges (Form 10-K Item 7).
Cancelled Project (FY2025)$71.1m reimbursement of costs from a customer on cancellation of a development and mass production project, recorded in FY2025 within the gain on cessation of business (Form 10-K).

9 Ownership, Voting Power & Annual Meeting

  • One class of common stock without par value; 52.88m shares outstanding at 13 Nov 2026 (Form 10-K cover), against 53.4m average diluted shares in FY2026.
  • Holders (Schedules 13G): BlackRock 8.22m shares (15.4%) at 31 Mar 2025; Vanguard Portfolio Management 2.71m (5.17%) at 30 Jun 2026; JPMorgan Chase 2.63m (5.0%) at 30 Jun 2026, cut to 1.82m (3.4%) at 30 Sep 2026; Victory Capital 2.24m (4.29%) at 30 Sep 2025. A 13F holder trend was not collected.
  • Annual meeting (4 Mar 2026): Peter T. Kong elected with 91.0% and Jon A. Olson with 97.6% of votes cast; PwC ratified with 99.3%; say on pay 94.2%.
  • Insiders, twelve months to 18 Nov 2026: no open market purchases; 14 open market sales of about $18.4m, of which $7.3m by Lester Wong on 18 Jun 2026 at $121.71, above the 18 Nov 2026 close of $66.99.
Table 9.1 Annual meeting vote results, 4 Mar 2026
ProposalFor (m votes)Against (m votes)Abstain (m votes)For as % of votes castResult
Election of director: Peter T. Kong39.83.9n/a91.0Elected (against = withheld)
Election of director: Jon A. Olson42.71.1n/a97.6Elected (against = withheld)
Ratify PricewaterhouseCoopers for FY202646.10.30.199.3Approved
Say on pay (non binding)41.12.50.194.2Approved
Directors on the 2026 ballot: Peter T. Kong and Jon A. Olson; the Against column shows withheld votes. Broker non votes of 2.85m excluded. For as % of votes cast excludes abstentions. Results from the Form 8-K Item 5.07 of 5 Mar 2026.

Annual meeting of 4 Mar 2026

  • No transcript, prepared remarks or presentation for the meeting was filed with the SEC; the vote results above come from the Form 8-K Item 5.07 of 5 Mar 2026.
Table 9.2 Open market sales by insiders, 19 Nov 2025 to 18 Nov 2026
InsiderRoleSalesDetail
Lester WongInterim CEO and CFO, then CFO$7.30m60,000 shares at $121.71 (18 Jun 2026)
Nelson WongSenior Vice President$6.09m90,004 shares Dec 2025 to Jun 2026 at $50.07 to $113.72; 70,000 under Rule 10b5‑1 plans
Mui Sung YeoDirector$3.38m19,143 shares at $71.98 (13 Feb 2026); 20,000 at $100.00 (20 May 2026)
David RichardsonDirector$0.68m9,364 shares at $72.20 (25 Feb 2026)
Robert ChylakSenior Vice President$0.52m7,098 shares at $73.28 (10 Feb 2026)
Zi Yao LimGeneral Counsel$0.27m3,500 shares in three sales, Dec 2025 to May 2026
Peter KongChair$0.17m1,551 shares at $110.00 (11 Jun 2026)
Forms 4. Totals are shares times reported weighted average prices. Tax withholding on vesting awards, award grants and gifts are excluded. No open market purchases were reported.

10 Risk Factors

  • Item 1A of the FY2026 Form 10-K holds 34 risk factors against 33 and fell from 10,973 to 9,558 words: two factors were added (personal data and the use of AI), one tax factor was merged and 12 were materially reworded. Each FY2026 Form 10-Q reported no material change to the FY2025 factors.
Table 10.1 Risk factors and disclosures with filed figures
RiskDisclosure and change
China exposure and export controlsChina destination sales 67.2% of FY2026 revenue; customers headquartered in China 56.3%; the export factor now names BIS controls on advanced computing and high bandwidth memory.
Customer concentrationHaoseng Industrial 16.1% and Tianshui Huatian 13.5% of FY2026 revenue; 32.6% and 22.2% of receivables at 3 Oct 2026 (54.8% together).
Order cancellation and backlogBacklog $720.3m, most of it cancellable or deferrable with limited or no penalties; purchase obligations $608.7m.
Cyclical demandRevenue fell from $1.50bn in FY2022 to $654.1m in FY2025 before rising to $1.18bn in FY2026; the 10-K states that visibility is limited.
Advanced Solutions returnsSegment operating loss of ($38.4m) in FY2026 on $112.7m of revenue; segment capital expenditure $17.1m of $27.1m for all segments (Note 15); cash paid for property, plant and equipment $21.8m.
Supply and logisticsSupply of certain chips, components and materials was constrained at times in FY2026; Super Typhoon Bavi disrupted freight in Jun and Jul 2026.

How risk factors changed

  • Comparison: 10-K FY2026 filed 19 Nov 2026 acc 0000056978-26-000040 against 10-K FY2025 filed 20 Nov 2025 acc 0000056978-25-000081.
  • Item 1A grew to 34 factors from 33 and fell to 9,558 words from 10,973.
  • Two factors were added, both on technology: personal data and the use of AI.
  • The export control factor now names BIS controls on high bandwidth memory and advanced computing, the markets behind the Advanced Solutions growth.
Figure 10.1 Risk factors by change against the prior filing
Table 10.2 Size of the risk factor section
Measure10-K FY202510-K FY2026
Risk factors (count)3334
Words in Item 1A10,9739,558
Table 10.3 Risk factors added, removed and materially reworded
ChangeRisk factorWhat changed
AddedProcessing of personal dataNew factor on US state privacy laws and the EU General Data Protection Regulation and the cost of complying with differing rules.
AddedUse of AI and emerging technologiesNew factor: AI in business processes brings risks of inaccurate output, data leakage and loss of confidential information under AI rules that differ by US state and country.
RemovedOther changes in taxationMerged into the tax factor, now titled changes in effective tax rate or tax legislation.
RewordedPolitical instability, tensions and warText on the Israel and Gaza conflict and the Haifa capillary plant removed; the factor is 187 words shorter.
RewordedDependence on suppliersStates that in FY2026 supply of certain chips, components and specialized materials was constrained at times; earlier text on easing constraints removed.
RewordedQuarterly results fluctuateBullet list replaced by one paragraph naming order cancellations, component costs, restructuring and inventory write offs; 97 words shorter.
RewordedOperations outside the USList of plants by country removed; the factor is 308 words shorter.
RewordedCatastrophic events and climateTaiwan earthquake example of Jan 2025 replaced by Super Typhoon Bavi, which disrupted freight between Jun and Jul 2026.
RewordedExport restrictions and trade warsRewritten around the Export Administration Regulations and BIS controls on semiconductors, advanced computing and high bandwidth memory; 419 words shorter.
RewordedCustomer concentrationAdds Haoseng Industrial at 16.1% of FY2026 revenue.
RewordedCessation of the EA businessWind down now substantially completed, subject to last time orders.
RewordedKey employeesRefers to the retirement in FY2026 of the former CEO and of the head of K&S Products and Solutions.
RewordedIT disruptions and cyber attacksRewritten to name insider threats, third party failures and attacks that use AI; 459 words shorter.
RewordedNew ERP systemShortened by 140 words; names data integrity issues, delays and cost overruns.
RewordedEffective tax rate and tax lawAdds valuation allowances, transfer pricing and the Jan 2026 OECD side by side safe harbor for US parented groups; OBBBA text removed.
Table 10.4 Risk factor updates in quarterly reports since the annual filing
FilingChange disclosed
10-Q Q1 FY2026 filed 5 Feb 2026No material change from the FY2025 risk factors.
10-Q Q2 FY2026 filed 7 May 2026No material change from the FY2025 risk factors.
10-Q Q3 FY2026 filed 6 Aug 2026No material change from the FY2025 risk factors.

11 Stock Price, Scenarios & Sensitivity

  • Kulicke & Soffa closed at $66.99 on 18 Nov 2026, 49.9% below the 1 Jul 2026 close of $133.81 (intraday 52 week high $135.80) and 73.2% above the 52 week intraday low of $38.67 of 20 Nov 2025.
  • Valuation: 19.6x FY2026 diluted EPS of $3.42 and 17.0x non GAAP EPS of $3.95; market value $3.54bn on 52.88m shares (Form 10-K cover); enterprise value $3.03bn after net cash of $517.0m, 2.6x FY2026 revenue. Teradyne traded at 27.0x and Onto Innovation at 66.1x TTM diluted EPS on the same day.
  • Scenario model: revenue grows from FY2026 $1.18bn for three years at the stated rate; operating margin as stated; $15m a year of interest income; 21% tax; share count changes as stated. Growth, margin, exit P/E and share count are assumptions of this report and are not company guidance.
Figure 11.1 KLIC monthly closing price and three year scenarios

Critical factors and core assumptions

Table 11.1 Critical factors behind the best case
FactorCurrent valueBest case requiresEvidence in filings
Ball Bonding demandQ4 FY2026 $271.4m, +198.3%; FY2026 $768.0m, +162.2%segment revenue holds near the FY2026 Q4 rate through FY2027 instead of falling back toward FY2023 to FY2025 levelsFY2026 Form 10-K; 8-K Ex 99.1 of 18 Nov 2026
TCB and Advanced SolutionsFY2026 $112.7m, operating loss ($38.4m)TCB system sales toward the up to about $400m a year that the expanded production is to support, with a segment profit8-K Ex 99.1 of 6 May and 18 Nov 2026
Orders and backlogbacklog $720.3m; FY2026 bookings $1.66bnbookings above revenue in FY2027FY2026 Form 10-K Item 7
Operating marginQ4 FY2026 21.2%; FY2026 17.9%26% in FY2029; FY2022 margin was 31.3%Forms 10-K
China customersChina 67.2% of FY2026 destination salesno new export rules that cut China revenueFY2026 Form 10-K Item 1A and Note 15
Capital return$10.4m of buybacks in FY2026 as stated in the release ($10.5m paid in the cash flow statement); $223.3m authorization left; $0.82 a share dividendshare count down about 2% by FY2029FY2026 Form 10-K Item 5
  • Base year FY2026: revenue $1.18bn, operating income $211.8m (17.9% margin), diluted EPS $3.42, non GAAP EPS $3.95.
  • Best case: 20% revenue CAGR, 26% operating margin, 22x P/E, share count (2%); FY2029 revenue about $2.0bn, above the FY2022 peak of $1.50bn.
  • Base case: 8% revenue CAGR, 20% operating margin, 17x P/E, share count (1%).
  • Worst case: (12%) revenue CAGR, 8% operating margin, 16x P/E, no change in shares; FY2029 revenue of about $806m sits between the FY2023 and FY2025 levels, when operating margins were 5.3%, (13.1%) and (0.5%).
  • Fixed inputs: 21% tax rate against 21.1% in FY2026; 52.88m shares before the stated changes.

Scenarios, three years forward

Table 11.2 Scenario analysis, FY2026 to FY2029
MeasureWorst caseBase caseBest case
Revenue CAGR, 3 years (%)(12.0)8.020.0
Revenue, FY2029 ($bn)0.81.52.0
Operating margin, FY2029 (%)8.020.026.0
Net income, FY2029 ($bn)0.10.20.4
EPS, FY2029 ($)1.194.728.33
Exit P/E (x)16.017.022.0
Implied price ($)1980183
Change against $66.99 (%)(72)20174
Implied annual return (%)(34.3)6.239.9
Implied annual return excludes dividends ($0.82 a share a year at the current rate).
Figure 11.2 Three year price scenarios

Sensitivity analysis

Table 11.3 Sensitivity of implied price to revenue CAGR and operating margin at 17x P/E
Revenue CAGR \ Operating margin8%14%20%23%26%
(12%)$20$33$45$51$58
0%$28$46$65$74$83
8%$34$57$80$92$103
14%$40$67$94$107$121
20%$46$77$109$124$140
Cells show implied share price in year 3. Close of 18 Nov 2026 $66.99. Blue cells sit above it, red cells below.
Table 11.4 Sensitivity of implied price to exit P/E and operating margin at 8% revenue CAGR
Exit P/E \ Operating margin8%14%20%23%26%
12x$24$40$57$65$73
14x$28$47$66$76$85
17x$34$57$80$92$103
20x$41$67$94$108$121
22x$45$74$104$119$134
Cells show implied share price in year 3. Close of 18 Nov 2026 $66.99. Blue cells sit above it, red cells below.

Disclaimer

This analysis is for information only and is not financial advice. It is derived from public SEC filings retrieved via sec-api.io and is not a publication of the U.S. Securities and Exchange Commission. Scenario values are model outputs under stated assumptions and are not forecasts. Data as of 19 November 2026.

Sources

All company figures are read from SEC filings retrieved through the sec-api.io MCP server, under central index key 56978 (Kulicke and Soffa Industries, Inc.). Peer figures come from the Forms 10-Q and 10-K of Teradyne and Onto Innovation and the Forms 8-K of Applied Materials. Share prices are closes of 18 Nov 2026 (Applied Materials 12 Nov 2026) and monthly closes.

Table A.1 Filings used, with accession numbers
FormPeriodFiledAccession number
10-KFY202619 Nov 20260000056978-26-000040
8-K Ex 99.1Q4 FY202618 Nov 20260000056978-26-000038
8-K Ex 10.113 Oct 202614 Oct 20260000056978-26-000036
8-K Ex 10.1, 99.113 Aug 202617 Aug 20260000056978-26-000034
10-QQ3 FY20266 Aug 20260000056978-26-000032
8-K Ex 99.1Q3 FY20265 Aug 20260000056978-26-000030
10-QQ2 FY20267 May 20260000056978-26-000020
8-K Ex 99.1Q2 FY20266 May 20260000056978-26-000018
8-K Item 5.074 Mar 20265 Mar 20260000056978-26-000014
10-QQ1 FY20265 Feb 20260000056978-26-000012
8-K Ex 99.1Q1 FY20264 Feb 20260000056978-26-000010
DEF 14A2026 annual meeting22 Jan 20260000056978-26-000006
10-KFY202520 Nov 20250000056978-25-000081
8-K Ex 99.1Q4 FY202519 Nov 20250000056978-25-000078
8-K Ex 99.1Q3 FY20256 Aug 20250000056978-25-000070
8-K Ex 99.1Q2 FY20256 May 20250000056978-25-000054
8-K Ex 99.1Q1 FY20254 Feb 20250000056978-25-000027
10-KFY202414 Nov 20240000056978-24-000148
10-KFY202316 Nov 20230000056978-23-000172
Schedule 13G/A30 Sep 202613 Oct 20260000019617-26-000359
Schedule 13G30 Jun 202631 Jul 20260002100121-26-000957
Schedule 13G30 Jun 202616 Jul 20260000019617-26-000267
Schedule 13G/A13 Mar 202626 Mar 20260000102909-26-000424
Schedule 13G/A30 Sep 202531 Oct 20250001040188-25-000088
Schedule 13G/A31 Mar 202530 Apr 20250002052113-25-001959
Table A.2 Forms 4 (example) and peer filings used
CompanyFormFiledAccession number
Kulicke & Soffa4 (59 transactions, example)22 Jun 20260001529306-26-000003
Applied Materials8-K Ex 99.113 Aug 20260001628280-26-056699
Applied Materials8-K26 Oct 20260001628280-26-067303
Applied Materials8-K Ex 99.112 Nov 20260001628280-26-073360
Onto Innovation10-K24 Feb 20260001193125-26-066937
Onto Innovation10-Q9 Nov 20260001193125-26-453859
Teradyne10-K19 Feb 20260001193125-26-059002
Teradyne10-Q30 Oct 20260001193125-26-441091
Table B.1 Exhibits to Forms 8-K filed in the last twelve months
FiledExhibitDocumentContent
19 Nov 2025Ex 99.1Q4 and FY2025 results releaseQ4 FY2025 revenue $177.6m; GAAP EPS $0.12; non GAAP EPS $0.28; FY2025 revenue $654.1m; net income $0.2m; gross margin 42.5%
4 Feb 2026Ex 99.1Q1 FY2026 results releaseRevenue $199.6m; gross margin 49.6%; GAAP EPS $0.32; non GAAP EPS $0.44; Operating cash flow ($8.9m); buybacks $6.7m
6 May 2026Ex 99.1Q2 FY2026 results releaseRevenue $242.6m; gross margin 49.3%; GAAP EPS $0.66; non GAAP EPS $0.79; FY2026 capex to about $22m from about $12m for TCB capacity of up to about $400m a year
5 Aug 2026Ex 99.1Q3 FY2026 results releaseRevenue $330.4m; gross margin 47.8%; GAAP EPS $1.07; non GAAP EPS $1.20; Expanded Advanced Solutions facility to be completed in H2 FY2027
17 Aug 2026Ex 10.1Offer letter, Dr. Raj TalluriSalary $750,000; target bonus 110% of salary; New hire equity award $14.0m (50% RSUs, 50% PSUs on relative TSR); annual award $6.0m
17 Aug 2026Ex 99.1CEO appointment releaseRaj Talluri CEO from 1 Sep 2026; previously CEO of Enovix and SVP at Micron; Lester Wong remains EVP and CFO
14 Oct 2026Ex 10.1Amended Incentive Compensation Plan (FY2027)Operating profit and gross margin, 50% each, replace net income and operating margin; Executive Leadership Team awards 85% corporate, 15% individual goals
18 Nov 2026Ex 99.1Q4 and FY2026 results releaseQ4 revenue $410.3m; GAAP EPS $1.37; non GAAP EPS $1.52; FY2026 revenue $1.18bn; GAAP EPS $3.42; non GAAP EPS $3.95; adjusted free cash flow $50.2m